CereVasc
DJ Cass has an extensive work experience in the healthcare industry. DJ started their career at Cytyc-Hologic in 2002, where they worked as a PMR and later as an Account Executive and Regional Imager Specialist. In 2008, they joined Hologic, Inc. as a District Sales Manager and later held positions as Sales Training, Regional Business Director, and Director of Strategic Planning. In 2014, DJ Cass joined Insulet as Vice President and General Manager, Neighborhood Diabetes, and went on to hold roles as Vice President Global Strategic Alliances, General Manager, Europe, and Group Vice President, International. Currently, DJ Cass is the SVP of Business Development and Strategy at CereVasc, a position they have held since 2020.
DJ Cass completed a Bachelor of Arts degree in Policy Studies from Syracuse University, attending from 1994 to 1998. Prior to that, from 1990 to 1994, they attended DeSales, although no specific degree or field of study was provided. Later, in 2012 and 2013, DJ Cass pursued a Master of Business Administration (M.B.A.) degree at Bentley University - McCallum Graduate School of Business.
This person is not in any teams
CereVasc
CereVasc is a medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. Current treatment of these patients requires an invasive, neurosurgical procedure with a documented rate of success well below the success rate for other neurosurgical interventions. The eShunt System hasthe potential to significantly improve patient outcomes and substantially decrease the overall cost of surgical treatment of this life-threatening condition.